Harry D. Rowland is Senior Vice President of Implantable Heart Failure Management (IHFM) Innovation at Edwards Lifesciences, following the acquisition of Endotronix. He was previously co-founder and CEO of Endotronix, a medtech digital health company dedicated to advancing the treatment of heart failure with the Cordella Heart Failure System and Cordella PA Sensor System. Dr. Rowland led the company since inception, first as CTO and subsequently as CEO and President, from concept through prototyping, $100M+ in financing, FDA premarket approval, organizational growth to 150+ team members, M&A with Edwards, and commercial launch. He received his PhD in mechanical engineering from the Georgia Institute of Technology, a BS in mechanical engineering, and a MA in economics from the University of California, Santa Barbara.